# Amgen Inc. (AMGN) — Q1-2017 Earnings Results

**Report date:** 2017-04-26 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q1-2017

## Post-Earnings Brief

### Headline

Amgen Beats on EPS, Stock Down 0.05%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $3.15 | N/A | +5.18% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed confidence in the company's strategic direction. They noted the importance of maintaining momentum in their product offerings.

**Key quotes:**

> Management highlighted strong performance in key therapeutic areas.

> They emphasized ongoing commitment to innovation and pipeline development.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Amgen's earnings report showed a positive surprise on EPS, indicating better-than-expected profitability. However, the stock reacted slightly down, which may suggest investor caution or profit-taking. The lack of revenue figures and guidance could have contributed to the muted stock performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q1-2017_